Ikarian Capital »

Scholar Rock Hldg Corp shares owned by Ikarian Capital

Quarter-by-quarter ownership of Scholar Rock Hldg Corp (SRRK) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Scholar Rock Hldg Corp

Tip: Access up to 7 years of quarterly data

All positions including Scholar Rock Hldg Corp held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scholar Rock Hldg Corp by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 654k 17.76
2021-03-31 $4.8M 95k 50.66
2020-12-31 $5.7M 117k 48.52

More positions owned by Ikarian Capital

Krystal Biotech Put Option (KRYS)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Alnylam Pharmaceuticals (ALNY)
Crinetics Pharmaceuticals In (CRNX)
Sarepta Therapeutics (SRPT)
Corcept Therapeutics Incorporated Put Option (CORT)
Tarsus Pharmaceuticals (TARS)
Disc Medicine (IRON)
Soleno Therapeutics (SLNO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Astrazeneca Sponsored Adr Call Option (AZN)
Bridgebio Pharma (BBIO)
Eyepoint Pharmaceuticals Com New (EYPT)
Biomea Fusion Put Option (BMEA)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Scholar Rock Hldg Corp

Artal Group
FMR
T. Rowe Price Associates
Samsara BioCapital
Redmile Group
BlackRock
State Street Corporation
OrbiMed Advisors
Vanguard Group
Polar Capital Holdings
Bellevue Group
Eventide Asset Management
Goldman Sachs Group
Geode Capital Management
Woodline Partners

View all funds holding Scholar Rock Hldg Corp